Revision of double-tapered, titanium, fully hydroxyapatite-coated femoral stems: ease of extraction and subsequent reconstruction.

Abstract

Fully hydroxyapatite coated, double-tapered, titanium stems are the most commonly used uncemented implants in the UK with survivorship reported at 96.3% at 23 years however there is no literature on the consequences of revision. We aimed to explore the reasons for failure, ease of stem extraction, extent of bone loss and complexity of the subsequent reconstruction. Between December 2012 and March 2019, 104 cases requiring removal of the Corail® stem (DePuy Synthes, Warsaw, IN, USA) were identified from the National Joint Registry (NJR) and our local revision database. Indication for revision, surgical/reconstruction technique, complications and follow-up data were reviewed. The common reasons for revision were aseptic loosening 45.2%, infection 23.5%, instability 4.8% and peri-prosthetic fracture 12.5%. Removal of the implant without extended trochanteric osteotomy (ETO) was achieved in 94.2% of cases. Of those revised for aseptic loosening 23% were proximal, 38% were proximal/mid stem and 38% all zones. Significant bone loss is not a common feature of the failure of this stem with 95% graded as a Paprosky grade 2 or less. In terms of reconstruction, 69.2% were revised to a primary cemented stem. In the majority of cases revision can be achieved without an ETO and reconstruction possible using a primary stem as significant bone loss is not a common feature of failure of this stem design. We conclude that this stem is safe to use in younger patients who may outlast any type of primary implant and would inevitably face revision in their lifetime.